Access to Healthcare and Well-being Fund

MARKETING COMMUNICATION

This UCITS fund focuses on publicly listed companies actively expanding global access to essential healthcare services, medicines, and wellness solutions. The fund's portfolio prioritizes companies with a low Measurable Impact Fund Efficiency Ratio (MIFER), which represents the investment cost per new individual with improved healthcare access. This approach aims to align financial returns with measurable social impact.

INVESTMENT OBJECTIVE AND APPROACH
The fund invests in companies across various healthcare sectors, including pharmaceuticals, medical devices, healthcare delivery systems, and wellness solutions. Companies are selected based on both their potential to improve healthcare access and their financial soundness, with a particular focus on innovations that make healthcare more accessible and affordable in underserved regions.

RISKS AND REWARDS
Investing in this fund carries risks that investors should carefully consider:
- The value of investments can fall as well as rise
- Healthcare markets may be subject to regulatory changes and policy shifts
- Companies may face challenges in developing markets and healthcare delivery
- Currency risk may affect the value of foreign investments

Past performance is not a reliable indicator of future results.

LIQUIDITY
As a UCITS fund, investors can typically redeem their investment on any business day, subject to the terms set out in the fund documentation.

KEY INFORMATION
Before investing, please read the:
- Key Investor Information Document (KIID)
- Prospectus
- Latest annual and semi-annual reports

These documents, along with the fund's performance data and other important information, are available at [website] or from your financial advisor.

The MIFER metric, expressed in GBP per new individual with improved healthcare access, helps quantify the investment required to achieve specific social impact. A lower MIFER indicates greater efficiency in improving healthcare access per pound invested.

For UK investors: Information about accessing the Financial Ombudsman Service (FOS) and the Financial Services Compensation Scheme (FSCS) can be found in the prospectus.